Ability Biotherapeutics at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Ability Biotherapeutics at BIO-Europe 2026 in Cologne: 1 session (1 workshop).

OrganizationBIO-Europe 2026 Attendance
Ability Biotherapeutics
Montreal, Canada
Biotech
Develops conditionally activated and multispecific antibodies for cancer and autoimmune diseases, using a generative AI discovery platform.
Talk
Mon Nov 9
09:00–10:00
Building Your BD Career: What Really Moves the Needle
What it takes to build a career in drug licensing and partnership deals, from scientific and financial skills to credibility and contacts.
with Thuja Capital, Merck KGaA, Tubulis

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ability Biotherapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction